Literature DB >> 20605794

Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin.

Kazuhiro Yamamoto1, Kaoru Miyazaki, Shouichi Higashi.   

Abstract

Localization of secreted matrix metalloproteinases (MMPs) on the cell surface is required not only for processing of cell surface proteins, but also for controlled degradation of the extracellular matrix (ECM). Our previous study demonstrated that binding of MMP-7 (matrilysin) to cell surface cholesterol sulfate (CS) is essential for the cell membrane-associated proteolytic action of this MMP. In this study, we investigated the role of CS in the MMP-7-catalyzed degradation of protein components of ECM. We found that the degradation of laminin-332 (laminin-5) catalyzed by MMP-7 was accelerated dramatically in the presence of CS, whereas the sulfated lipid inhibited the degradation of casein catalyzed by the protease. The MMP-7-catalyzed degradation of fibronectin was partially inhibited in the presence of low concentrations of CS, whereas it was accelerated significantly at high concentrations of the lipid. Therefore, it is likely that CS alters the substrate preference of MMP-7. We also found that the proteins of which MMP-7-catalyzed degradation were accelerated by CS also had affinities for CS, suggesting that CS facilitates the proteolyses by cross-linking MMP-7 to its substrates. Moreover, MMP-7 tethered to cancer cell surface via CS degraded fibronectin and laminin-332 coated on a culture plate. The degradations of the adhesive proteins led to significant detachment of the cells from the plate. Taken together, our findings provide a novel mechanism in which cell surface CS promotes the proteolytic activities of MMP-7 toward selective substrates in the pericellular ECM, thereby contributing to cancer cell migration and metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605794      PMCID: PMC2937913          DOI: 10.1074/jbc.M110.136994

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Structure and function of matrix metalloproteinases and TIMPs.

Authors:  Hideaki Nagase; Robert Visse; Gillian Murphy
Journal:  Cardiovasc Res       Date:  2006-01-05       Impact factor: 10.787

2.  The short arm of laminin gamma2 chain of laminin-5 (laminin-332) binds syndecan-1 and regulates cellular adhesion and migration by suppressing phosphorylation of integrin beta4 chain.

Authors:  Takashi Ogawa; Yoshiaki Tsubota; Junko Hashimoto; Yoshinobu Kariya; Kaoru Miyazaki
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

3.  Matrilysin 1 influences colon carcinoma cell migration by cleavage of the laminin-5 beta3 chain.

Authors:  Lionel Remy; Cécile Trespeuch; Sophie Bachy; Jean-Yves Scoazec; Patricia Rousselle
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

Review 4.  The other side of MMPs: protective roles in tumor progression.

Authors:  Michelle D Martin; Lynn M Matrisian
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

5.  Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor.

Authors:  Shouichi Higashi; Kaoru Miyazaki
Journal:  J Biol Chem       Date:  2008-01-31       Impact factor: 5.157

6.  Cytokine secretion via cholesterol-rich lipid raft-associated SNAREs at the phagocytic cup.

Authors:  Jason G Kay; Rachael Z Murray; Julia K Pagan; Jennifer L Stow
Journal:  J Biol Chem       Date:  2006-03-02       Impact factor: 5.157

7.  Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion.

Authors:  Kazuhiro Yamamoto; Shouichi Higashi; Mitomu Kioi; Jun Tsunezumi; Koichi Honke; Kaoru Miyazaki
Journal:  J Biol Chem       Date:  2006-02-13       Impact factor: 5.157

8.  Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway.

Authors:  Eric T Sawey; Johnny A Johnson; Howard C Crawford
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

9.  Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.

Authors:  Jun Tsunezumi; Kazuhiro Yamamoto; Shouichi Higashi; Kaoru Miyazaki
Journal:  FEBS J       Date:  2008-08-21       Impact factor: 5.542

10.  PI(4,5)P2-dependent microdomain assemblies capture microtubules to promote and control leading edge motility.

Authors:  Tamara Golub; Pico Caroni
Journal:  J Cell Biol       Date:  2005-04-04       Impact factor: 10.539

View more
  7 in total

Review 1.  Peripheral membrane associations of matrix metalloproteinases.

Authors:  Steven R Van Doren; Tara C Marcink; Rama K Koppisetti; Alexander Jurkevich; Yan G Fulcher
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-23       Impact factor: 4.739

2.  Charge-Triggered Membrane Insertion of Matrix Metalloproteinase-7, Supporter of Innate Immunity and Tumors.

Authors:  Stephen H Prior; Yan G Fulcher; Rama K Koppisetti; Alexander Jurkevich; Steven R Van Doren
Journal:  Structure       Date:  2015-10-01       Impact factor: 5.006

3.  Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.

Authors:  Banu K Arun; Yun Gong; Diane Liu; Jennifer K Litton; Angelica M Gutierrez-Barrera; J Jack Lee; Lana Vornik; Nuhad K Ibrahim; Terri Cornelison; Gabriel N Hortobagyi; Brandy M Heckman-Stoddard; Kimberly B Koenig; Ricardo R Alvarez; James L Murray; Vicente Valero; Scott M Lippman; Powel Brown; Nour Sneige
Journal:  Breast Cancer Res Treat       Date:  2016-06-10       Impact factor: 4.872

4.  Macrophages induce "budding" in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions.

Authors:  Kari Trumpi; Nicola Frenkel; Timo Peters; Nicoline M Korthagen; Jennifer M J Jongen; Daniëlle Raats; Helma van Grevenstein; Yara Backes; Leon M Moons; Miangela M Lacle; Jan Koster; Danny Zwijnenburg; Inne H M Borel Rinkes; Onno Kranenburg
Journal:  Oncotarget       Date:  2018-04-13

5.  Metabolomics guided pathway analysis reveals link between cancer metastasis, cholesterol sulfate, and phospholipids.

Authors:  Caroline H Johnson; Antonio F Santidrian; Sarah E LeBoeuf; Michael E Kurczy; Nicholas J W Rattray; Zahra Rattray; Benedikt Warth; Melissa Ritland; Linh T Hoang; Celine Loriot; Jason Higa; James E Hansen; Brunhilde H Felding; Gary Siuzdak
Journal:  Cancer Metab       Date:  2017-10-31

6.  Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α.

Authors:  Xiongjie Shi; Qiuqiong Cheng; Leyuan Xu; Jiong Yan; Mengxi Jiang; Jinhan He; Meishu Xu; Maja Stefanovic-Racic; Ian Sipula; Robert Martin O'Doherty; Shunlin Ren; Wen Xie
Journal:  Mol Cell Biol       Date:  2013-11-25       Impact factor: 4.272

7.  Amino-terminal fragments of laminin γ2 chain retract vascular endothelial cells and increase vascular permeability.

Authors:  Hiroki Sato; Jun Oyanagi; Eriko Komiya; Takashi Ogawa; Shouichi Higashi; Kaoru Miyazaki
Journal:  Cancer Sci       Date:  2014-01-07       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.